Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis
ObjectiveTo determine the short-term effectiveness safety of baricitinib in children with refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting.MethodsThis was a single-center retrospective study, including 20 children with rsJDM. They were all treated using baricitinib c...
Saved in:
Main Authors: | Zhaoling Wang (Author), Qi Zheng (Author), Wenjie Xuan (Author), Xisheng Xu (Author), Meiping Lu (Author), Jianqiang Wu (Author), Lixia Zou (Author), Yiping Xu (Author), Xuefeng Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
by: Meiping Lu, et al.
Published: (2023) -
Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study
by: Xuefeng Xu, et al.
Published: (2022) -
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
by: Jianqiang Wu, et al.
Published: (2023) -
Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis
by: Ryder C, et al.
Published: (2011) -
Successful Therapy of Severe and Refractory Cutaneous Sarcoidosis with Baricitinib
by: Giuseppe Russo, et al.
Published: (2024)